217 related articles for article (PubMed ID: 34303375)
1. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.
Wu X; Li J; Yan T; Ke X; Li X; Zhu Y; Yang J; Li Z
Cancer Cell Int; 2021 Jul; 21(1):393. PubMed ID: 34303375
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
3. TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma.
Zhang W; Li J; Wu Y; Ge H; Song Y; Wang D; Yuan H; Jiang H; Wang Y; Cheng J
Cancer Cell Int; 2018; 18():178. PubMed ID: 30459528
[TBL] [Abstract][Full Text] [Related]
4. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
[TBL] [Abstract][Full Text] [Related]
5. MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.
Zhang W; Huang X; Huang R; Zhu H; Ye P; Lin X; Zhang S; Wu M; Jiang F
Comput Math Methods Med; 2022; 2022():3058342. PubMed ID: 36105241
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
[TBL] [Abstract][Full Text] [Related]
7. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
[TBL] [Abstract][Full Text] [Related]
8. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J
J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991
[TBL] [Abstract][Full Text] [Related]
9. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J
J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583
[TBL] [Abstract][Full Text] [Related]
11. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
12. NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.
Tao W; Tian G; Xu S; Li J; Zhang Z; Li J
Cancer Cell Int; 2021 Aug; 21(1):413. PubMed ID: 34362389
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma.
Wu Y; Wang Y; Diao P; Zhang W; Li J; Ge H; Song Y; Li Z; Wang D; Liu L; Jiang H; Cheng J
Theranostics; 2019; 9(6):1777-1793. PubMed ID: 31037138
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma.
Li Z; Chen C; Wang J; Wei M; Liu G; Qin Y; She L; Liu Y; Huang D; Tian Y; Zhu G; Zhang X
PeerJ; 2021; 9():e10746. PubMed ID: 33520474
[TBL] [Abstract][Full Text] [Related]
18. JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4.
Jing C; Liu D; Lai Q; Li L; Zhou M; Ye B; Wu Y; Li H; Yue K; Wu Y; Duan Y; Wang X
Cancer Cell Int; 2021 Jul; 21(1):375. PubMed ID: 34261480
[TBL] [Abstract][Full Text] [Related]
19. Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
Li J; Liu X; Nan S; Xu C
Free Radic Res; 2020 Apr; 54(4):254-270. PubMed ID: 32462956
[TBL] [Abstract][Full Text] [Related]
20. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]